-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
PLUS THERAPEUTICS, INC. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q2 2010 to Q3 2025.
- PLUS THERAPEUTICS, INC. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 107M shares, a 1268% increase year-over-year.
- PLUS THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 7.7M shares, a 145% increase from 2023.
- PLUS THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 3.14M shares, a 79.4% increase from 2022.
- PLUS THERAPEUTICS, INC. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.75M shares, a 85.5% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)